CYPRUS
Total # cancer cases (2018)
Total # cancer deaths (2018)
4,829 2,376
29.2%
aPAF, cancer deaths bPAF, cancer cases cPAF, melanoma cases
TRENDS
Estimated past and future trends in total cases per year (breast and lung) Probability of premature death from cancer per year
INVESTMENT CASE (2019)
*High income
At this income level, investing in a package of essential services and scaling-up coverage will:
Costs per year Projected lives saved per year
BURDEN OF CANCER
44.9%
Total population (2019)
Tobacco (2017)a Alcohol (2016)a Infections (2012)b Obesity (2012)b
5.4% 6.0%
1,198,574
Premature deaths from NCDs (2016)
Cancer as % of NCD premature deaths (2016)
4.8%
PAFs
(population attributable fractions)
1,668
Cancer Country Profile 2020
UV (2012)c Occupational risk (2017)a
62.1% 6.5%
15.0%
3.4%
10.6%
2.9%
2.8%
10.0%
3.6%
2.4%
15.6%
6.4%
7.5%
4.1%
10.2%
1.6%
5.6%
20.7%
3.5%
5.6%
8.0%
0.3%
Breast Bladder Colorectum Corpus uteri Leukaemia Lung Non-Hodgkin lymphoma Pancreas Prostate Thyroid
Most common cancer cases (2018)
Incidence Mortality
0 0 0 0 0 1 1 1 1 1 1
2020 2022 2024 2026 2028 2030
6.44%
6.48%6.29%6.71%6.44%6.11%6.20%6.24%6.06%6.64%
6.17%5.90%6.21%6.53%
6.01%
6.11%6.10%6.08%6.07%6.06%6.04%6.03%6.02%6.00%5.99%5.98%5.96%
5.95%
5.63%5.50%5.37%5.24%5.12%4.99%4.86%4.73%4.60%4.48%4.35%4.22%
4.09%
2.00%
7.00%
12.00%
17.00%
2000 2005 2010 2015 2020 2025 2030
Past trends Projected linear trend SDG target 604
276 725
485 1,038
814
- 200 400 600 800 1,000 1,200
Breast cancer Lung cancer
2012 2018 2040
- 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00
2020 2022 2024 2026 2028 2030
US$ (per capita)
CYPRUS
HEALTH SYSTEM CAPACITY
aper 10,000 cancer patients
WORKFORCE
aper 10,000 cancer patients
Quality of mortality registration*** 2007-2016 Low 2019 yes
# of radiation oncologista 2019 n/a
2019 124.2
# of mammographsa 2020 89.0 # of surgeonsa 2012 292.0
# of CT scannersa 2020 60.1 # of radiologista 2019 320.2
# of MRI scannersa 2020 37.3 # of nuclear medicine physiciana 2019 14.5
# of PET or PET/CT scannersa 2020 4.1 # of medical & pathology lab scientistsa 2008 45.6
Integrated NCD plan 2019 n/a 2019 2.1
NCCP (including cancer types) 2019 operational 2019 4 cancer(s)
MPOWER measures fully implemented and
achieved 2018
1
Pathology services 2019 generally availableCancer management guidelines 2019 no 2019 generally available
Palliative care included in their operational,
integrated NCD plan 2019 n/a
2015-2017 1933
Breast cancer screening program 2019 yes
*Defined daily doses for statistical purposes (S-DDD) per miliion inhabitants per day Breast cancer screening program: Starting
age, target population 2019
50
GLOBAL INITIATIVES
Elimination of Cervical Cancer Global Initiative for Childhood Cancer
HPV vaccination programme coverage 2018 63.8 2020 36
Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes
Screening programme type 2019 opportunistic Defined referral system 2019 yes
Screening programme method 2019 PAP smear
Screening participation rates 2019
Early detection programme/guidelines 2019 yes
Defined referral system 2019 yes
***The mortality estimates for this country have a high degree of uncertainty because they are not based on any national NCD mortality data 70% or more
Annual cancer cases (0-14 years old) Bone marrow transplantation capacity
# Public cancer centres per 10,000 cancer patients
# of treatment services (surgery,
radiotherapy, chemotherapy) 2019 3 Availability of opioids* for pain
management Availability of population-based cancer
registry (PBCR)** 2019
# of external beam radiotherapy (photon,electron)a
Cancer Country Profile 2020
High quality PBCR
2019 14.5
FORMULATING RESPONSE
Annual cancer cases (0-14 years old) Palliative care availability:
community/home-based care 2019 generally available Available staff in Ministry of Health who
dedicates significant proportion of their time to cancer
# of medical physicista
Early detection programme/ guidelines for 4 cancers (breast, cervix, colon, childhood)
8
2 1 4 2 1 18
Acute lymphoid leukaemia Hodgkin lymphoma Burkitt lymphoma CNS, low grade tumours Retinoblastoma Wilms tumour Other childhood cancer
